NEWS & VIEWS

Global private equity and venture capital news and research

Posts Tagged ‘GlaxoSmithKline’

11 February 2015

Edmond de Rothschild sells GlycoVaxyn for $212m

cells5_sq Edmond de Rothschild Investment Partners has sold vaccine biopharmaceutical company GlycoVaxyn to GlaxoSmithKline in a deal worth $212m.

5 December 2014

GSK abandons $3bn-plus plan to sell older drugs portfolio

pills-1111307-m Pharmaceutical giant GlaxoSmithKline has decided not to sell a portfolio of older drugs marketed in North America and Europe, despite strong interest from private equity firms and offers upwards of $3bn.

14 November 2014

Apollo rivals KKR in $3bn bid for older medicines from drugmaker GSK

drug-pharma-medical-healthcare Private equity firm Apollo Global Management is reportedly set to join the $3bn auction for a set of older medicines from drugmaker GlaxoSmithKline.

30 May 2014

GSK looks to sell older drugs to buyout firms

meddd GlaxoSmithKline is reportedly looking to sell a range of its older drugs to private equity firms.

11 November 2013

London pension fund major appoints GSK director Robert Vandersluis to board

Robert Vandersluis LPFA UK government pension major the London Pensions Fund Authority has brought in GlaxoSmithKline’s director of global pension investments Robert Vandersluis as a non-executive director and board member.

9 August 2013

GlaxoSmithKline launches $50m venture capital fund

biomed_lrg Pharmaceutical major GlaxoSmithKline (GSK) has launched a $50m venture capital fund to invest in bioelectronic medicines and technologies.


Legals & Terms of UsePrivacy Policy


AltAssets is registered as a trademark of Investor Networks Limited (06695690).
Registered Office: Zetland House, 5-25 Scrutton St, London EC2A 4HJ
Content is © AltAssets 2000-2015